Entity Common Stock, Shares Outstanding of Adverum Biotechnologies, Inc. from 31 Aug 2014 to 07 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Adverum Biotechnologies, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Aug 2014 to 07 Nov 2025.
  • Adverum Biotechnologies, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 07 Nov 2025 was 22,077,467, a 6.1% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Adverum Biotechnologies, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 22,077,467 +1,275,004 +6.1% 07 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 20,984,161 +183,258 +0.88% 05 Aug 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 20,890,540 -186,658,612 -90% 04 Apr 2025 10-K 15 Apr 2025 2024 FY
Q3 2024 20,802,463 -80,224,711 -79% 31 Oct 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 20,800,903 -80,192,107 -79% 02 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 207,549,152 +106,989,861 +106% 08 Mar 2024 10-K 18 Mar 2024 2023 FY
Q3 2023 101,027,174 +1,298,149 +1.3% 31 Oct 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 100,993,010 +1,659,432 +1.7% 04 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 100,559,291 +1,808,574 +1.8% 17 Mar 2023 10-K 30 Mar 2023 2022 FY
Q3 2022 99,729,025 +1,576,935 +1.6% 04 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 99,333,578 +1,207,712 +1.2% 05 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 98,750,717 +815,940 +0.83% 18 Mar 2022 10-K 29 Mar 2022 2021 FY
Q3 2021 98,152,090 +674,487 +0.69% 29 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 98,125,866 +17,469,215 +22% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 97,934,777 +18,253,520 +23% 29 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 97,477,603 +32,889,557 +51% 30 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 80,656,651 +16,197,419 +25% 03 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 79,681,257 +16,246,638 +26% 28 Feb 2020 10-K 12 Mar 2020 2019 FY
Q3 2019 64,588,046 +1,719,667 +2.7% 31 Oct 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 64,459,232 +1,765,158 +2.8% 31 Jul 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 63,434,619 +1,162,718 +1.9% 30 Apr 2019 10-Q 08 May 2019 2019 Q1
Q3 2018 62,868,379 +17,826,911 +40% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 62,694,074 +19,407,288 +45% 31 Jul 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 62,271,901 +19,402,740 +45% 30 Apr 2018 10-Q 09 May 2018 2018 Q1
Q3 2017 45,041,468 +3,322,953 +8% 31 Oct 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 43,286,786 +1,938,592 +4.7% 31 Jul 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 42,869,161 +15,737,964 +58% 30 Apr 2017 10-Q 09 May 2017 2017 Q1
Q3 2016 41,718,515 +15,959,185 +62% 31 Oct 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 41,348,194 +15,672,305 +61% 29 Jul 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 27,131,197 +1,602,275 +6.3% 29 Apr 2016 10-Q 06 May 2016 2016 Q1
Q3 2015 25,759,330 +3,502,052 +16% 31 Oct 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 25,675,889 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 25,528,922 30 Apr 2015 10-Q 13 May 2015 2015 Q1
Q3 2014 22,257,278 31 Aug 2014 10-Q 12 Sep 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.